BioSpace News Archive

Initiation of Expanded Access Program follows FDA granting Fast Track Designation of onvansertib for second-line treatment of patients with KRAS-mutation mCRC

Leading assistive technology provider Cognixion announces the launch of a revolutionary new AI-powered product with Lincare AAC, a division of Lincare Holdings Inc., and provider of oxygen and other respiratory therapy services to patients nationwide.

L7 Informatics announced today that it has been recognized as a 2020 Cool Vendor in Gartner’s Cool Vendors in Life Sciences report.

The Ibn Sina Foundation announced it has launched rapid COVID-19 testing, together with CVS Health, at its Ibn Sina Wilcrest Community Clinic location.

Serimmune to map epitopes of current Twist antibodies - Twist to use epitopes to re-screen Twist libraries to identify & evaluate novel candidates

Enteris BioPharma, Inc. announced that John Vrettos, Ph.D., Senior Principal Scientist and Head of Formulation Development at Enteris, has been invited to participate in a webinar series hosted by BIODURO LLC highlighting advances in drug formulation and delivery.

BriaCell Therapeutics Corp., a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to announce that Dr. Bill Williams, BriaCell’s President & CEO, has been invited to present at 3rd Annual Next-Gen Immuno-Oncology Congress, a virtual event, will be held on June 25 - 26, 2020.

Aurinia Pharmaceuticals Inc. announced that additional safety data from the completed AURORA pivotal trial of voclosporin were shared at the European Renal Association-European Dialysis and Transplant Association 2020 Virtual Congress in an oral presentation given by nephrologist Dawn Caster, M.D., Assistant Professor of Medicine at the University of Louisville School of Medicine.

Annovis Bio Inc., a clinical-stage drug platform company addressing Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases, announced that CEO Maria Maccecchini, Ph.D. and CFO Jeff McGroarty, MBA, CPA, will give a virtual corporate presentation at the June 2020 Virtual Summer Investor Summit taking place online from June 9 to 12, 2020.

CereVasc, Inc., a company focused on improving the treatment of patients with hydrocephalus, announced today the closing of an expanded Series A financing that raised a total of $43.9 million led by the Perceptive Xontogeny Venture (PXV) Fund and ATON Partners,